Nubeva Technologies Ltd (NBVA : TSX-V)
Common Stock
$0.20
CAD
+0.00 (%)
Last updated: 2026-10-13
Follow NBVA
NBVA
Nubeva Technologies Ltd
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+5.26%
1 Month
-4.76%
YTD
+11.11%
Key Statistics
Market Cap
$14.03M
52W High
$0.27
52W Low
$0.12
P/E Ratio
-
50 Day MA
$0.17
200 Day MA
$0.16
Beta
0.90
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/13/2026 | $0.20 | $0.23 | $0.19 | $0.20 | $0.20 | 261,300 |
| 10/9/2026 | $0.19 | $0.20 | $0.19 | $0.20 | $0.20 | 216,544 |
| 10/8/2026 | $0.18 | $0.20 | $0.18 | $0.19 | $0.19 | 93,500 |
| 10/7/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 1,528 |
| 10/6/2026 | $0.18 | $0.19 | $0.18 | $0.19 | $0.19 | 160,000 |
| 10/5/2026 | $0.18 | $0.18 | $0.17 | $0.17 | $0.17 | 22,500 |
| 10/2/2026 | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 3,500 |
| 10/1/2026 | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 1,000 |
| 9/30/2026 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 123,166 |
| 9/29/2026 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 1,025 |
Analyst Price Targets
Based on analyst covering NBVA · as of Sep 17, 2026
Wall Street analysts forecast NBVA stock price to rise 1420.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.04
+1420.0% Upside
Current Price
C$0.20
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NBVA's historical volatility
30-Day Vol
110.7%
Annualized
90-Day Vol
130.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.21 | C$0.14 – C$0.31 |
| 60 trading days | C$0.23 | C$0.13 – C$0.39 |
| 90 trading days | C$0.24 | C$0.12 – C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Nubeva Technologies Ltd
Nubeva Technologies Ltd., together with its subsidiaries, develops and licenses software-based decryption solutions for businesses, governments, and other organizations in the United Kingdom, the United States, and Canada. The company offers Ransomware Reversal, which decrypts files and data encrypted by ransomware attacks to enable restoration of operations without the need to pay ransoms. It also provides cloud-based decryption and security software and services; support and maintenance services; and professional services associated with customizing its products. In addition, the company provides support for TLS (SSL) network decryption solutions. Nubeva Technologies Ltd. was founded in 2016 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $500,586
- EBITDA
- $-857,589
- Profit Margin
- -129.83%
- ROE (TTM)
- -22.25%
- EPS (Diluted)
- -0.01
- Book Value
- 0.05
Classification
- Sector
- Information Technology
- Industry
- Software
- Group
- Software & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NBVA
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RSC-P | Rockmount Capital Corporation | $0.12 | +380.00% |
| CTA | Centaurus Energy Inc | $5.08 | +138.50% |
| PUL | Pulse Oil Corp | $0.01 | +50.00% |
| EVNT | Eventer Technologies Ltd. | $1.50 | +41.51% |
| VIS | Visionstate Corp | $0.02 | +33.33% |
| NCI | NTG Clarity Networks Inc. | $0.42 | +33.33% |
| MAPS | Prostar Holdings Inc | $0.18 | +28.57% |
| OTMC | Oreterra Metals Corp. | $0.45 | +27.14% |
NBVA.V news timeline
15 articles covering NBVA.V, most recent first
Latest